Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment
Brain and Development · 2025
DOI: 10.1016/j.braindev.2025.104410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Development, 2025. Verfasst von Tamaki Kato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Rehabilitation Medicine, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Rehabilitation Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.
- Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: saito.kayoko@twmu.ac.jp.
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Kato, T., Otsuki, N., Yokomura, M., Shima, N., Kajima, K., Shioya, M., Suzuki, H., Wakabayshi, H., & Saito, K. (2025). Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104410
Vancouver
Kato T, Otsuki N, Yokomura M, Shima N, Kajima K, Shioya M, et al. Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104410
BibTeX
@article{Kato2025,
author = {Kato, Tamaki and Otsuki, Noriko and Yokomura, Mamoru and Shima, Naoko and Kajima, Kota and Shioya, Moeka and Suzuki, Hayato and Wakabayshi, Hidetaka and Saito, Kayoko},
title = {Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment},
journal = {Brain and Development},
year = {2025},
doi = {10.1016/j.braindev.2025.104410}
}
EUVIMED